Aprotinin versus lysine analogues: the debate continues (Q41752154)

8 October 2017

1 reference

title

Aprotinin versus lysine analogues: the debate continues (English)

1 reference

8 October 2017

Royston D

1

1 reference

8 October 2017

language of work or name

English

0 references

publication date

1 April 1998

1 reference

The Annals of Thoracic Surgery

8 October 2017

published in

1 reference

8 October 2017

volume

65

1 reference

8 October 2017

issue

4 Suppl

1 reference

8 October 2017

page(s)

S9-19; discussion S27-8

1 reference

Alpha 2-antiplasmin supplementation inhibits tissue plasminogen activator-induced fibrinogenolysis and bleeding with little effect on thrombolysis

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Bleeding time prolongation and bleeding during infusion of recombinant tissue-type plasminogen activator in dogs: Potentiation by aspirin and reversal with aprotinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Differential effects of aprotinin and tranexamic acid on cerebral bleeding and cutaneous bleeding time during rt-PA infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Influence of High-dose Aprotinin Treatment on Blood Loss and Coagulation Patterns in Patients Undergoing Myocardial Revascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

High does epsilon-aminocaproic acid prolongs the bleeding time and increases rebleeding and intraoperative hemorrhage in patients with subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

The dose-response relationship of tranexamic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Prevention of postbypass bleeding with tranexamic acid and epsilon-aminocaproic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Prevention of bleeding after cardiopulmonary bypass with high-dose tranexamic acid. Double-blind, randomized clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Tranexamic acid reduces postbypass blood use: a double-blinded, prospective, randomized study of 210 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Tranexamic acid significantly reduces blood loss associated with coronary revascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Decreased postoperative drainage with addition of epsilon-aminocaproic acid before cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Effect of aprotinin on vascular reactivity of coronary bypass grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Mechanisms involved in the induction of human endothelial cell necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

The effects of aprotinin on hemostatic function during cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Acceleration of phagocytosis in human neutrophils incubated with gabexate mesilate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Effect of aprotinin on neutrophil function after major vascular surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Effect of the Kallikrein Inhibitor Aprotinin on Myocardial Ischemia and Necrosis in Man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Aprotinin improves outcome of single-ventricle palliation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Double-orifice right atrioventricular valve associated with partial atrioventricular septal defect.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Fibrinolytic activity after subarachnoid haemorrhage and the effect of tranexamic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Therapeutic trial of cerebral vasospasm with the serine protease inhibitor, FUT-175, administered in the acute stage after subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Preventive effect of synthetic serine protease inhibitor, FUT-175, on cerebral vasospasm in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Aprotinin therapy in cardiac operations: a report on use in 41 cardiac centers in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

The role of bradykinin in mediating ischemic brain edema in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Effects of aprotinin on acute recovery of cerebral metabolism in piglets after hypothermic circulatory arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Aprotinin for coronary artery bypass grafting: Effect on postoperative renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Acute renal failure and myopathy after treatment with aminocaproic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Aminocaproic acid and "proteinuria".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Epsilon Aminocaproic Acid — A Dangerous Weapon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Effects of high-dose aprotinin on renal function in aortocoronary bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

High-dose aprotinin in cardiac surgery: three years' experience in 1,784 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Anaphylactic/anaphylactoid reactions during cardiac surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

[Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Anaphylactic reaction to aprotinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Severe anaphylactic shock due to repeated application of aprotinin in patients following intrathoracic aortic replacement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Prevalence of anaphylactic reactions to aprotinin: analysis of two hundred forty-eight reexposures to aprotinin in heart operations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Spontaneous thrombosis of ruptured intracranial aneurysms during treatment with tranexamic acid (AMCA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Cerebral Thrombosis Associated with Amicar Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Recurrent subarachnoid hemorrhage associated with aminocaproic acid therapy and acute renal artery thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Noninflammatory bullae associated with epsilon-aminocaproic acid infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Metabolism of Fibrinogen in Cirrhosis of the Liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Early thrombus formation on heparin-bonded pulmonary artery catheters in patients receiving epsilon aminocaproic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Fatal aortic thrombosis in a neonate during infusion of epsilon-aminocaproic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Intraoperative coronary thrombosis: can aprotinin and protamine be incriminated?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Early formation of thrombi on pulmonary artery catheters in cardiac surgical patients receiving high-dose aprotinin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Aprotinin and aortic cannula thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Aprotinin and thrombus formation on pulmonary artery catheters: a piece of the coagulation puzzle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Influence of aprotinin on early graft thrombosis in patients undergoing myocardial revascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Aprotinin in elective primary bypass surgery. Graft patency and clinical efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

Protease inhibitors (gebexate mesylate and ulinastatin) stimulate intracellular chemiluminescence in human neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Evidence for a Participation of the Kallikrein-Kinin System in the Regulation of Muscle Metabolism during Hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Anaphylactic reaction to aprotinin during cardiac surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900071-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0003-4975(98)00071-X

1 reference

8 October 2017

1 reference